{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:23:58Z","timestamp":1771514638493,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["P50CA116201"],"award-info":[{"award-number":["P50CA116201"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["P50 CA136393"],"award-info":[{"award-number":["P50 CA136393"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA098131"],"award-info":[{"award-number":["P50CA098131"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA06485"],"award-info":[{"award-number":["P30CA06485"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA289528"],"award-info":[{"award-number":["R01CA289528"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003923","name":"The Dr Susan Love Foundation for Breast Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003135","name":"Minnesota Ovarian Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mcpro.2025.101316","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:27:26Z","timestamp":1761121646000},"page":"101316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3835-9924","authenticated-orcid":false,"given":"Qiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1282-6016","authenticated-orcid":false,"given":"Hongming","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8321-102X","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Renuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Saddiq","family":"Zahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Kamrul Hasan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Mangalaparthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara Levin","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-7259","authenticated-orcid":false,"given":"S. John","family":"Weroha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7745-1614","authenticated-orcid":false,"given":"Xinyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2025.101316_bib1","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.101316_bib2","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1073\/pnas.94.17.9052","article-title":"P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase","volume":"94","author":"Myers","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.101316_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects","volume":"19","author":"Lee","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcpro.2025.101316_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/jcp.2008.056101","article-title":"Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints","volume":"62","author":"Llobet","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.mcpro.2025.101316_bib6","article-title":"PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5\/IGF1R pathway through ATF6","volume":"26","author":"Yu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.mcpro.2025.101316_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.146.2.389","article-title":"Shc and FAK differentially regulate cell motility and directionality modulated by PTEN","volume":"146","author":"Gu","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mcpro.2025.101316_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1234907","article-title":"A secreted PTEN phosphatase that enters cells to alter signaling and survival","volume":"341","author":"Hopkins","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.101316_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","article-title":"Ubiquitination regulates PTEN nuclear import and tumor suppression","volume":"128","author":"Trotman","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1236188","article-title":"Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress","volume":"341","author":"Bassi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.101316_bib12","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1158\/0008-5472.CAN-10-3399","article-title":"CREB is a novel nuclear target of PTEN phosphatase","volume":"71","author":"Gu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib13","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/hmg\/ddl177","article-title":"The ERK1\/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation","volume":"15","author":"Chung","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcpro.2025.101316_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2010.12.020","article-title":"Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner","volume":"144","author":"Song","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(03)00021-7","article-title":"PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms","volume":"3","author":"Freeman","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3892\/ijo.2014.2377","article-title":"The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review)","volume":"44","author":"Nakanishi","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mcpro.2025.101316_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molcel.2006.06.028","article-title":"Mechanistic insights into maintenance of high p53 acetylation by PTEN","volume":"23","author":"Li","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib18","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41416-020-0834-6","article-title":"Emerging role of PTEN loss in evasion of the immune response to tumours","volume":"122","author":"Vidotto","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcpro.2025.101316_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12964-020-00622-w","article-title":"Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma","volume":"18","author":"Zhao","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.mcpro.2025.101316_bib20","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcpro.2025.101316_bib21","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcpro.2025.101316_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/TCRM.S251668","article-title":"Role of alpelisib in the treatment of PIK3CA-Mutated breast cancer: patient selection and clinical perspectives","volume":"17","author":"Chang","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.mcpro.2025.101316_bib23","doi-asserted-by":"crossref","first-page":"P4-10-04","DOI":"10.1158\/1538-7445.SABCS19-P4-10-04","volume":"80","author":"Juric","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature13948","article-title":"Convergent loss of PTEN leads to clinical resistance to a PI(3)Kalpha inhibitor","volume":"518","author":"Juric","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.101316_bib25","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1158\/0008-5472.CAN-09-1067","article-title":"Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells","volume":"69","author":"Vitolo","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib26","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1038\/ncomms5961","article-title":"Activation of diverse signalling pathways by oncogenic PIK3CA mutations","volume":"5","author":"Wu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101316_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genomics Proteomics Bioinform."},{"key":"10.1016\/j.mcpro.2025.101316_bib28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neo.2017.04.007","article-title":"Prevention of human lymphoproliferative tumor Formation in ovarian cancer patient-derived xenografts","volume":"19","author":"Butler","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.mcpro.2025.101316_bib29","first-page":"234","article-title":"Endpoints for mouse abdominal tumor models: refinement of current criteria","volume":"59","author":"Paster","year":"2009","journal-title":"Comp. Med."},{"key":"10.1016\/j.mcpro.2025.101316_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.mcpro.2025.101316_bib32","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1021\/acs.jproteome.5b00302","article-title":"Activating mutations in PIK3CA lead to widespread modulation of the tyrosine phosphoproteome","volume":"14","author":"Zahari","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib33","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1021\/pr200611n","article-title":"Universal and confident phosphorylation site localization using phosphoRS","volume":"10","author":"Taus","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib34","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib35","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.101316_bib36","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.101316_bib37","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib38","doi-asserted-by":"crossref","first-page":"W304","DOI":"10.1093\/nar\/gkab359","article-title":"KEA3: improved kinase enrichment analysis via data integration","volume":"49","author":"Kuleshov","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib39","first-page":"1912","article-title":"A subcellular map of the human proteome","volume":"356 298","author":"Thul","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.101316_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib41","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","author":"Stark","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib42","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mcpro.2025.101316_bib43","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-018-0024-8","article-title":"Mutant KRAS-driven cancers depend on PTPN11\/SHP2 phosphatase","volume":"24","author":"Ruess","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2025.101316_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mcpro.2025.101316_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nbt1046","article-title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells","volume":"23","author":"Rush","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mcpro.2025.101316_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41388-021-02092-x","article-title":"Regulation of Src tumor activity by its N-terminal intrinsically disordered region","volume":"41","author":"Aponte","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.mcpro.2025.101316_bib47","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2025.01.024","article-title":"GUK1 activation is a metabolic liability in lung cancer","volume":"188","author":"Schneider","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib48","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/s41388-021-01714-8","article-title":"Oncogenic functions and therapeutic targeting of EphA2 in cancer","volume":"40","author":"Wilson","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.mcpro.2025.101316_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jgg.2021.02.011","article-title":"EphA2: a promising therapeutic target in breast cancer","volume":"48","author":"Zhao","year":"2021","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.mcpro.2025.101316_bib50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.101316_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.3978","article-title":"The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions","volume":"30","author":"Oughtred","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.mcpro.2025.101316_bib52","first-page":"4541","article-title":"Regulation by the autophosphorylation site in overexpressed pp60c-src","volume":"8","author":"Kmiecik","year":"1988","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mcpro.2025.101316_bib53","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.bjc.6604676","article-title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer","volume":"99","author":"Chang","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcpro.2025.101316_bib54","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcpro.2025.101316_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1596\/neo.12300","article-title":"Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells","volume":"14","author":"Lin","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.mcpro.2025.101316_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13058-022-01596-y","article-title":"SRC kinase-mediated signaling pathways and targeted therapies in breast cancer","volume":"24","author":"Luo","year":"2022","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib57","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0960-9822(99)80453-9","article-title":"Ubiquitin-dependent degradation of active Src","volume":"9","author":"Hakak","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mcpro.2025.101316_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1078-0432.CCR-15-0603","article-title":"EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer","volume":"22","author":"Dunne","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2012.02.053","article-title":"Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer","volume":"149","author":"Duncan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib60","first-page":"3147","article-title":"Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay","volume":"60","author":"Han","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib61","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-020-15943-0","article-title":"Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction","volume":"11","author":"Post","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101316_bib62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mcpro.2025.101316_bib63","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcpro.2025.101316_bib64","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/0008-5472.CAN-07-1182","article-title":"The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration","volume":"68","author":"Dey","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101316_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2020.09.027","article-title":"Control of Glucocorticoid receptor levels by PTEN establishes a failsafe mechanism for tumor suppression","volume":"80","author":"Yip","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/srep39985","article-title":"Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate","volume":"7","author":"Moniz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcpro.2025.101316_bib67","doi-asserted-by":"crossref","first-page":"11116","DOI":"10.1074\/jbc.M108670200","article-title":"PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit","volume":"277","author":"Mayo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.101316_bib68","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1089\/ars.2014.5843","article-title":"The PTEN\/NRF2 axis promotes human carcinogenesis","volume":"21","author":"Rojo","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mcpro.2025.101316_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.2309","article-title":"Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways","volume":"17","author":"Zhang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2025.101316_bib70","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41467-017-01574-5","article-title":"PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer","volume":"8","author":"Wozniak","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101316_bib71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","article-title":"Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling","volume":"8","author":"Lu","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2025.101316_bib72","article-title":"A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance","author":"Karunaraj","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.mcpro.2025.101316_bib73","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/1947601910395582","article-title":"Critical role of Shp2 in tumor growth involving regulation of c-Myc","volume":"1","author":"Ren","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.mcpro.2025.101316_bib74","doi-asserted-by":"crossref","first-page":"F960","DOI":"10.1152\/ajprenal.00020.2006","article-title":"Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases","volume":"291","author":"Baldwin","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.mcpro.2025.101316_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117325","article-title":"FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells","volume":"179","author":"Mezquita","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mcpro.2025.101316_bib76","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/ncomms4159","article-title":"SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2","volume":"5","author":"Naudin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101316_bib77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1083\/jcb.201205176","article-title":"EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion","volume":"201","author":"Sugiyama","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mcpro.2025.101316_bib78","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S1470-2045(17)30450-3","article-title":"Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"18","author":"Kim","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mcpro.2025.101316_bib79","first-page":"356","article-title":"Genomics and evolution of protein phosphatases","volume":"15","author":"Chen","year":"2017","journal-title":"Sci. Signal."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625004153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625004153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:10:28Z","timestamp":1766437828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947625004153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1535947625004153"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.101316","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.101316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101316"}}